CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 2, March/April 2022 78 AFRICA real-life data regarding the association of IPC and IPF with postoperative drainage and the need for transfusion in patients who had undergone CABG. We found that IPC decreased shortly after CABG compared to pre-operative values, however, IPC increased after the postoperative first day. Our findings show that pre-operative IPF and IPC had a significantly negative correlation with the amount of blood components transfused intra-operatively. Pre-operative IPF and IPC had a significant association with the total amount of blood components used throughout hospitalisation. These findings suggest that IPF and IPC could have significant value in predicting the need for postoperative drainage and postoperative blood transfusion. Conclusion Pre-operative IPC and IPF had a significant correlation with postoperative drainage volumes and the need for blood transfusion, and seemed to be important in predicting postoperative bleeding in patients undergoing CABG. Further research with a larger sample size may be required to understand the role of IP in coagulopathy after surgical procedures. Studies with a prospective design that stratify patients based on various other characteristics may aid the search for other parameters (especially blood indices) that could be utilised to predict excessive bleeding in this patient population. This work was supported by the Sysmex Turkey Diagnostic Systems Limited Company. References 1. Weiss A, Elixhauser A, Andrews R. Characteristics of operating room procedures in US hospitals, 2011. Statistical Brief 170, 2014. 2. Melly L, Torregrossa G, Lee T, et al. Fifty years of coronary artery bypass grafting. J Thorac Dis 2018; 10(3): 1960–1967. 3. Konstantinov IE. The first coronary artery bypass operation and forgotten pioneers. Ann Thorac Surg 1997; 64(5): 1522–1523. 4. Ellis J, Valencia O, Crerar-Gilbert A, et al. Point-of-care platelet function testing to predict blood loss after coronary artery bypass grafting surgery: a prospective observational pilot study. Perfusion 2016; 31(8): 676–682. 5. Benlachgar N, Doghmi K, Masrar A, et al. Immature platelets: a review of the available evidence. Thromb Res 2020; 195: 43–50. 6. Lev EI. Immature platelets: clinical relevance and research perspectives. Circulation 2016; 134(14): 987–988. 7. Kurahashi H, Takami A, Murotani K, et al. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction. Int J Hematol 2018; 107(1): 105–111. 8. Brescia AA, Vu JV, He C, Li J, et al. Determinants of value in coronary artery bypass grafting. Circ Cardiovasc Qual Outcomes 2020; 13(11): e006374. 9. Weininger G, Mori M, Brooks C, et al. Association between cardiac surgeons’ number of years in practice and surgical outcomes in New York cardiac centers. J Am Med Assoc Network Open 2020; 3(11): e2023671. 10. Rodríguez-Olivares R, López-Menéndez J, Barca LV, et al. Identification of candidates for coronary artery bypass grafting admitted with STEMI and multivessel disease. Cardiovasc Revasc Med Molec Intervent 2018; 19(6s): 21–26. 11. Farooq V, Serruys PW. Bypass grafting versus percutaneous intervention – which ıs better in multivessel coronary disease: lessons from SYNTAX and beyond. Prog Cardiovasc Dis 2015; 58(3): 316–334. 12. Sotomi Y, Cavalcante R, van Klaveren D, et al. Individual long-term mortality prediction following either coronary stenting or bypass surgery in patients with multivessel and/or unprotected left main disease: an external validation of the SYNTAX score II model in the 1,480 patients of the BEST and PRECOMBAT randomized controlled trials. J Am Coll Cardiol Cardiovasc Intervent 2016; 9(15): 1564–1572. 13. Piątek J, Kędziora A, Konstanty-Kalandyk J, et al. Risk factors for in-hospital mortality after coronary artery bypass grafting in patients 80 years old or older: a retrospective case-series study. Peer J 2016; 4: e2667. 14. Ichikawa J, Osada Y, Kodaka M, et al. Association between platelet count and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass and fresh frozen plasma administration guided by thromboelastometry. Jap Circ J 2018; 82(3): 677–683. 15. Zubair MM, Bailly DK, Lantz G, et al. Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 2015; 20(1): 24–30. 16. 16. Van Poucke S, Stevens K, Wetzels R, et al. Early platelet recovery following cardiac surgery with cardiopulmonary bypass. Platelets 2016; 27(8): 751–757. 17. McDonnell A, Bride KL, Lim D, et al. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk. Pediatr Blood Cancer 2018; 65(2). 18. Patel K, Adalti S, Runwal S, et al. Re-exploration after off-pump coronary artery bypass grafting: Incidence, risk factors, and impact of timing. J Card Surg 2020; 35(11): 3062–3069. 19. Rodino AM, Henderson JB, Dobbins KF, et al. Impact of thrombocytopenia on postoperative bleeding ıncidence in patients receiving aspirin following coronary artery bypass grafting. J Pharmacy Prac 2020: 897190020966193. 20. Sadeghi R, Babahajian A, Sarveazad A, et al. Dual antiplatelet therapy before coronary artery bypass grafting; a systematic review and metaanalysis. Arch Academic Emerg Med 2020; 8(1): e61.
RkJQdWJsaXNoZXIy NDIzNzc=